119 related articles for article (PubMed ID: 8280828)
1. Case-control study of risk factors for cervical squamous-cell neoplasia in Denmark. III. Role of oral contraceptive use.
Kjaer SK; Engholm G; Dahl C; Bock JE; Lynge E; Jensen OM
Cancer Causes Control; 1993 Nov; 4(6):513-9. PubMed ID: 8280828
[TBL] [Abstract][Full Text] [Related]
2. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill.
Vessey MP; Lawless M; McPherson K; Yeates D
Lancet; 1983 Oct; 2(8356):930-4. PubMed ID: 6138502
[TBL] [Abstract][Full Text] [Related]
3. Oral contraceptives and cervical cancer risk in Costa Rica. Detection bias or causal association?
Irwin KL; Rosero-Bixby L; Oberle MW; Lee NC; Whatley AS; Fortney JA; Bonhomme MG
JAMA; 1988 Jan; 259(1):59-64. PubMed ID: 3334773
[TBL] [Abstract][Full Text] [Related]
4. Case-control study of risk factors for cervical squamous cell neoplasia in Denmark. IV: role of smoking habits.
Kjaer SK; Engholm G; Dahl C; Bock JE
Eur J Cancer Prev; 1996 Oct; 5(5):359-65. PubMed ID: 8972255
[TBL] [Abstract][Full Text] [Related]
5. Oral contraceptive use and cervical intraepithelial neoplasia.
Coker AL; McCann MF; Hulka BS; Walton LA
J Clin Epidemiol; 1992 Oct; 45(10):1111-8. PubMed ID: 1474407
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for cervical neoplasia in Denmark.
Kjaer SK
APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
[TBL] [Abstract][Full Text] [Related]
7. Oral contraceptives and gynecologic cancer: an update for the 1990s.
Kaunitz AM
Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1171-6. PubMed ID: 1415442
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer risk and use of depot-medroxyprogesterone acetate in Costa Rica.
Oberle MW; Rosero-Bixby L; Irwin KL; Fortney JA; Lee NC; Whatley AS; Bonhomme MG
Int J Epidemiol; 1988 Dec; 17(4):718-23. PubMed ID: 2976059
[TBL] [Abstract][Full Text] [Related]
9. Comparison of oral contraceptive use in women with adenocarcinoma and squamous cell carcinoma of the uterine cervix.
Honoré LH; Koch M; Brown LB
Gynecol Obstet Invest; 1991; 32(2):98-101. PubMed ID: 1748331
[TBL] [Abstract][Full Text] [Related]
10. Oral contraceptives and cancer of the cervix uteri. A meta-analysis.
Delgado-Rodriguez M; Sillero-Arenas M; Martin-Moreno JM; Galvez-Vargas R
Acta Obstet Gynecol Scand; 1992 Jul; 71(5):368-76. PubMed ID: 1326213
[TBL] [Abstract][Full Text] [Related]
11. Oral contraceptives and cervical cancer--further findings from the Oxford Family Planning Association contraceptive study.
Zondervan KT; Carpenter LM; Painter R; Vessey MP
Br J Cancer; 1996 May; 73(10):1291-7. PubMed ID: 8630295
[TBL] [Abstract][Full Text] [Related]
12. Oral contraceptive use and cancer: final report from the Oxford-Family Planning Association contraceptive study.
Vessey M; Yeates D
Contraception; 2013 Dec; 88(6):678-83. PubMed ID: 24090961
[TBL] [Abstract][Full Text] [Related]
13. [Possible link between long-term oral contraceptive use and cervical cancer].
Perspect Int Planif Fam; 1987; (Spec No):40-1. PubMed ID: 12269054
[TBL] [Abstract][Full Text] [Related]
14. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection.
Daling JR; Madeleine MM; McKnight B; Carter JJ; Wipf GC; Ashley R; Schwartz SM; Beckmann AM; Hagensee ME; Mandelson MT; Galloway DA
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):541-8. PubMed ID: 8827359
[TBL] [Abstract][Full Text] [Related]
15. Female hormone utilisation and risk of hepatocellular carcinoma.
Tavani A; Negri E; Parazzini F; Franceschi S; La Vecchia C
Br J Cancer; 1993 Mar; 67(3):635-7. PubMed ID: 8382515
[TBL] [Abstract][Full Text] [Related]
16. Oral contraceptive use and invasive cervical cancer.
Parazzini F; la Vecchia C; Negri E; Maggi R
Int J Epidemiol; 1990 Jun; 19(2):259-63. PubMed ID: 2376433
[TBL] [Abstract][Full Text] [Related]
17. Oral contraceptive use and risk of invasive cervical cancer.
Brinton LA; Reeves WC; Brenes MM; Herrero R; de Britton RC; Gaitan E; Tenorio F; Garcia M; Rawls WE
Int J Epidemiol; 1990 Mar; 19(1):4-11. PubMed ID: 2351522
[TBL] [Abstract][Full Text] [Related]
18. Cervical carcinoma in situ and use of depot-medroxyprogesterone acetate (DMPA). WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
Thomas DB; Ye Z; Ray RM
Contraception; 1995 Jan; 51(1):25-31. PubMed ID: 7750280
[TBL] [Abstract][Full Text] [Related]
19. Barrier methods of contraception and the risk of cervical neoplasia.
Parazzini F; Negri E; La Vecchia C; Fedele L
Contraception; 1989 Nov; 40(5):519-30. PubMed ID: 2692961
[TBL] [Abstract][Full Text] [Related]
20. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
